Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astragalus granules plus PD-1 inhibitor and chemotherapy in advanced gastric cancer
ChiCTR2300068896Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Mar 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of astragalus granules in gastric cancer (GC) (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Objective response rate. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
astragalus granules
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2300068896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068896.